Novartis AG ADR (NVS) Is Now En Route to Higher Prices

Novartis AG ADR (NYSE: NVS) is 2.07% higher on its value in year-to-date trading and has touched a low of $92.35 and a high of $120.92 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The NVS stock was last observed hovering at around $103.40 in the last trading session, with the day’s loss setting it -0.34%.

Currently trading at $103.06, the stock is -5.71% and -8.90% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.44 million and changing -0.33% at the moment leaves the stock -3.19% off its SMA200. NVS registered 9.87% gain for a year compared to 6-month gain of 0.48%. The firm has a 50-day simple moving average (SMA 50) of $113.1328 and a 200-day simple moving average (SMA200) of $106.4581.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The stock witnessed a -11.54% loss in the last 1 month and extending the period to 3 months gives it a -11.10%, and is -3.18% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 0.88% over the week and 0.95% over the month.

Novartis AG ADR (NVS) has around 76057 employees, a market worth around $201.64B and $48.59B in sales. Current P/E ratio is 12.02 and Fwd P/E is 12.48. Profit margin for the company is 36.23%. Distance from 52-week low is 11.60% and -14.77% from its 52-week high. The company has generated returns on investments over the last 12 months (25.64%).

with sales reaching $12.79B over the same period.The EPS is expected to grow by 17.44% this year, but quarterly earnings will post 11.09% year-over-year. Quarterly sales are estimated to grow 12.01% in year-over-year returns.

Novartis AG ADR (NVS) Top Institutional Holders

The shares outstanding are 2.04B, and float is at 1.96B with Short Float at 0.24%.

The top institutional shareholder in the company is DODGE & COX with over 12.24 million shares valued at $1.3 billion. The investor’s holdings represent 0.5987% of the NVS Shares outstanding. As of 2024-06-30, the second largest holder is PRIMECAP MANAGEMENT CO/CA/ with 12.18 million shares valued at $1.3 billion to account for 0.5959 of the shares outstanding. The other top investors are MORGAN STANLEY which holds 7.42 million shares representing 0.3629% and valued at over $789.58 million, while DIMENSIONAL FUND ADVISORS LP holds 0.3624 of the shares totaling 7.41 million with a market value of $788.63 million.